Hot Literature: What can we learn from the consensus statement on leptospirosis?
A new report, based on a literature review, offers a consensus opinion on leptospirosis and provides evidence-based justification for recommendations regarding the diagnosis, treatment, and prevention of this disease. This consensus statement was presented at the 2010 American College of Veterinary Internal Medicine (ACVIM) forum and was published in the Jan./Feb. 2011 issue of the Journal of Veterinary Internal Medicine.
Here are some of the questions the consensus statement may help us answer.
1. WHAT CLINICAL SIGNS ARE ASSOCIATED WITH CANINE LEPTOSPIROSIS?
2. WHAT ARE THE RISK FACTORS THAT PREDISPOSE DOGS TO LEPTOSPIROSIS?
Typically, dogs become infected with leptospirosis by exposure to contaminated water, soil, food, or bedding that comes in contact with mucous membranes or abraded skin. Outbreaks of leptospirosis tend to be seen after periods of high rainfall, but peak incidence overall varies geographically. Intact male working dogs that are kept outdoors are at risk, but infection may occur in males and females of any breed or age. Dogs that drink from or are exposed to rivers, streams, or lakes may have an increased risk; however, it is important to note that even dogs in urban environments may contract the illness. "In areas where wild animal species access suburban backyards, small-breed dogs with minimal contact with water sources may be at risk," the panel notes.
3. DO CATS BECOME ILL FROM LEPTOSPIROSIS?
Leptospirosis has been isolated from cats, but clinical disease is rare. Whether cats may play a role in environmental contamination is not clear.
4. WHAT IS THE BEST WAY TO DIAGNOSE LEPTOSPIROSIS?
The current test of choice is still the microscopic agglutination test (MAT), which tests for antibodies to various leptospirosis serovars. The concern with this methodology is that interpretation is subjective and standardization is difficult. Dogs that are acutely ill may have negative test results within the first week of illness, so measuring acute and convalescent titers (seven to 14 days apart) is recommended. A fourfold increase in the titer is supportive of a recent infection. Previous vaccination against leptospirosis may also cause an elevated titer, and vaccine serovars may cross-react with nonvaccine serogroups. Postvaccinal titers are expected to be low, but high titers (≥ 1,600) may persist after vaccination. Thus, while a single elevated titer may raise suspicion for leptospirosis, it does not confirm the disease.
In dogs with acute illness (< 10 days) that would likely have negative serologic test results, molecular diagnostics such as polymerase chain reaction (PCR) testing may be more beneficial. In dogs with a history of leptospirosis vaccination and positive serologic test results, PCR testing can confirm active infection. Negative PCR results do not rule out the disease, and the test still needs to be interpreted in conjunction with antibody testing and supportive clinical signs. PCR testing of urine in dogs with known current or previous leptospirosis infection may help identify a chronic carrier state.
5. IF I DIAGNOSE LEPTOSPIROSIS IN A PATIENT, WILL CLINICAL SIGNS OR SEROLOGY RESULTS IDENTIFY WHICH IS THE INFECTIVE SEROVAR?
According to the panel, "at this time, no clear correlation has been made between the suspected infecting serovar based on antibody testing and clinical manifestations of disease in naturally occurring canine leptospirosis." In the future, a combination of tests including genetic studies may ultimately aid in the correlation of clinical signs and infecting leptospiral strain and allow more specific mapping of the geographic distribution of leptospirosis. The treatment of leptospirosis is the same regardless of the infecting serovar.